Bulk Pharmaceutical API Sources for PROCARBAZINE HYDROCHLORIDE

Bulk Pharmaceutical API Sources for PROCARBAZINE HYDROCHLORIDE

Vendor	Vendor Homepage	Vendor Sku	API Url
NIH Clinical Collection		SAM001246564
NovoSeek		9703
ISpharm		I06-0654
MolPort		MolPort-003-849-975
Hangzhou APIChem Technology		AC-12163

Bulk Active Pharmaceutical Ingredient (API) Sources for: Procarbazine Hydrochloride

Last updated: August 5, 2025

Introduction

Procarbazine hydrochloride is a chemotherapeutic agent primarily used in the treatment of Hodgkin’s lymphoma and other malignancies. As an alkylating agent, it interferes with DNA synthesis, leading to apoptosis of fast-dividing cancer cells. Its manufacturing hinges critically on sourcing high-purity bulk APIs. Reliable suppliers of procarbazine hydrochloride are essential for pharmaceutical companies to ensure uninterrupted production, regulatory compliance, and drug efficacy. This article reviews the key sources, industry landscape, quality standards, and strategic considerations for sourcing procarbazine hydrochloride API in bulk.

Understanding Procarbazine Hydrochloride API

Procarbazine hydrochloride (C12H17N3O·HCl) is synthesized via complex chemical processes involving multiple intermediates, typically requiring strict quality controls at each step. The purity level mandated by pharmacopeias such as the USP or EP is generally ≥ 98%. The manufacturing process involves chemical stability considerations to prevent degradation or impurity formation, making sourcing from reputable suppliers vital.

Major API Manufacturing Regions and Key Suppliers

1. China

China dominates global pharmaceutical API manufacturing, accounting for over 50% of the world's API production capacity due to its cost advantages, extensive manufacturing infrastructure, and a broad supplier base. Major Chinese API producers for chemotherapeutic agents, including procarbazine hydrochloride, include:

• Hubei Yitai Pharmaceutical Co., Ltd.
  Specializes in oncology APIs with certifications aligning with GMP standards.

• Shandong Xinhua Pharmaceutical Co., Ltd.
  Offers bulk APIs with a focus on chemotherapeutic agents.

• South China Pharmaceutical Co., Ltd.
  Provides comprehensive API manufacturing, including complex alkylating agents.

Note: While Chinese suppliers offer cost-effective options, verification of GMP compliance, third-party audits, and regulatory adherence (e.g., FDA, EMA approvals) are vital due to variability.

2. India

India's pharmaceutical industry is renowned for high-quality APIs, especially for oncology drugs. Key players include:

• Lupin Limited
  Known for a robust API manufacturing division adhering to cGMP standards.

• Aurobindo Pharma
  Offers a wide portfolio of chemotherapeutic APIs, including potential procarbazine hydrochloride sources.

• Sun Pharmaceutical Industries
  Focuses on high-potency APIs with comprehensive quality assurance.

India’s API manufacturing often emphasizes regulatory compliance and quality standards, making it suitable for markets with stringent regulations.

3. Europe and North America

While the production of complex APIs like procarbazine hydrochloride is less prevalent due to higher costs, certain specialized manufacturers operate in Europe and the U.S.:

• Fresenius Kabi (Germany)
  Provides a range of oncology APIs with high regulatory standards.

• Teva Pharmaceuticals (Israel)
  Offers chemotherapeutic APIs with a focus on quality and regulatory compliance.

• Bristol-Myers Squibb (U.S.)
  Engages in contract manufacturing of specific chemotherapeutic agents, often for proprietary use.

These sources primarily supply APIs for niche markets, clinical applications, or as contract manufacturing partners.

Key Sourcing Considerations

Regulatory Compliance: Suppliers must hold current Good Manufacturing Practice (GMP) certification and have undergone audits by regulatory authorities such as the FDA or EMA. This ensures quality, safety, and efficacy of the API.

Quality Assurance: Given the potency and toxicity of chemotherapy agents, pure API (> 98% purity) with minimal impurities is imperative. Certificates of Analysis (CoA), stability data, and impurity profiles should be scrutinized.

Supply Reliability: Long-term supply agreements may mitigate risks of shortage or delays. Supply chain transparency, manufacturing capacity, and contingency planning are critical.

Pricing and Lead Time: Cost competitiveness must be balanced against quality and regulatory compliance. Lead times can vary; strategic partnerships can improve responsiveness.

Challenges in Sourcing Procarbazine Hydrochloride API

• Limited Suppliers: Few manufacturers globally produce procarbazine hydrochloride at scale, leading to potential supply tightness.

• Regulatory Variability: Suppliers from different regions may have varying levels of compliance, impacting approvals in specific markets.

• Complex Manufacturing: The synthetic process has multiple steps with strict control points, which may affect scalability and consistency.

• Intellectual Property Rights: While procarbazine is off-patent, some proprietary manufacturing processes or intermediates could pose licensing issues.

Emerging Trends and Future Outlook

• Vertical Integration: Larger pharmaceutical firms may prefer in-house synthesis or exclusive supplier relationships for supply security.

• Quality Harmonization: Increasing global regulatory convergence aims to harmonize manufacturing standards, easing cross-border sourcing.

• Alternative Synthesis Routes: Research into more efficient or greener synthetic routes could expand supplier pools and reduce costs.

• Supply Chain Diversification: Companies are diversifying suppliers across regions to mitigate geopolitical or logistical risks.

Conclusion

Sourcing bulk procarbazine hydrochloride API requires navigating a landscape characterized by regional manufacturing strengths, stringent quality requirements, and complex supply chains. Predominantly, Chinese and Indian manufacturers serve as primary sources, offering cost advantages balanced by the need for meticulous quality assessments. For high-regulatory markets in Europe and North America, selecting suppliers with proven GMP compliance and robust quality systems is essential. Strategic sourcing, combined with thorough due diligence and supplier audits, can ensure secure, compliant, and cost-effective procurement of procarbazine hydrochloride API.

---

Key Takeaways

• Procarbazine hydrochloride API is primarily supplied by Chinese and Indian manufacturers, with additional niche sources in Europe and North America.

• Regulatory compliance and strict quality standards are non-negotiable due to the drug's cytotoxic nature.

• Reliable supply chain management and supplier audits are critical to mitigate shortages and ensure consistent quality.

• The complex synthetic process necessitates careful assessment of manufacturing capacity and technical expertise of suppliers.

• Emerging industry trends include supply chain diversification, harmonization of quality standards, and process innovation.

---

FAQs

Q1: What are the primary regions producing procarbazine hydrochloride API?
A: China and India are the dominant API manufacturing regions for procarbazine hydrochloride, supported by European and North American specialty suppliers for high-regulatory markets.

Q2: What quality standards should be verified when sourcing procarbazine hydrochloride?
A: Suppliers should have GMP certification, provide Certificates of Analysis, demonstrate compliance with pharmacopeial purity specifications (≥ 98%), and supply impurity profiles aligned with regulatory requirements.

Q3: Are there alternatives to traditional sourcing for procarbazine hydrochloride?
A: Yes. Contract manufacturing organizations (CMOs) with proprietary synthesis capabilities and emerging synthetic routes may serve as alternative sources, often offering tailored supply arrangements.

Q4: What are the biggest risks in sourcing procarbazine hydrochloride API?
A: Key risks include supply shortages, regulatory non-compliance, quality inconsistencies, and geopolitical or logistical disruptions affecting manufacturing or shipping.

Q5: How can companies ensure API quality from overseas suppliers?
A: Conduct comprehensive audits, validate GMP certificates, review Certificates of Analysis, perform independent testing, and establish long-term quality partnerships to ensure consistent API quality.

---

References

[1] U.S. Pharmacopeia (USP). Procarbazine hydrochloride monograph.
[2] European Pharmacopoeia (EP). Oncology API standards.
[3] Industry Reports on Global API Manufacturing.
[4] Chinese Pharmaceutical Industry Data.
[5] Indian Pharmaceutical Sector Overview.